Archives
-
CGRP/SP–Piezo2 Signaling in Trigeminal Neuralgia
2026-10-05
Liao et al. identify a Ca2+-dependent CGRP/SP–Piezo2 feedback mechanism linking trigeminal root compression, neuroinflammation, and mechanical allodynia. The study provides a mechanistic framework for interpreting peripheral sensitization in trigeminal neuralgia while also showing why cAMP-related observations should not be equated automatically with PKA-specific causality.
-
YAP-TEAD Control of Surface Ectoderm Fate
2026-10-05
Wang et al. map how super-enhancers and three-dimensional chromatin contacts contribute to early surface ectoderm commitment from pluripotent stem cells. Their perturbation data support YAP-TEAD as an upstream regulator that promotes early super-enhancer establishment, target-gene activation, and differentiation, while also defining important limits for translation beyond the reported model.
-
Prednisolone as a Mechanistic Probe in ERAD
2026-10-04
Prednisolone is a synthetic glucocorticoid useful for interpreting glucocorticoid signaling, inflammation modulation, and cellular responses to corticosteroids. This article distinguishes those receptor-mediated effects from the ERAD-engaging degradation platform reported by Song et al., defining what the evidence supports—and what it does not.
-
Streptavidin-HyperFluor 647 in Research Context
2026-10-03
Streptavidin-HyperFluor™ 647 is presented by APExBIO as a red-emitting streptavidin fluorescent conjugate for detecting biotinylated molecules. Its conceptual relevance spans fluorescence microscopy, flow cytometry, antibody-based detection, and selected FRET designs. However, the supplied evidence is primarily product-level information rather than an independent performance study. The 2026 BmTyr proximity-labeling paper provides useful context but describes a deliberately biotin-free, azide-compatible platform, so it does not directly validate Streptavidin-HyperFluor 647. This overview separates supplier claims from peer-reviewed findings, compares the evidence bases, and defines the main limitations affecting interpretation and applicability.
-
Periodontopathogens Redirect RAS Toward Angiotensin (1-7)
2026-10-02
Waligórska and colleagues show that Porphyromonas gingivalis and Tannerella forsythia use surface-associated PepO metalloproteases to hydrolyze angiotensin I and favor formation of Angiotensin (1-7). Structural, biochemical, cellular, and infection-model data connect periodontal proteolysis with local renin–angiotensin system remodeling while also defining important limits on translation to human disease.
-
Pronase E Workflows for Proteomic Sample Prep
2026-10-01
Pronase E is a broad-spectrum protease mixture for controlled protein digestion, peptide mapping, and proteomics-oriented sample preparation. This guide connects practical digestion workflows with assay decisions inspired by a recent TNBC ferroptosis study, while separating established findings from optimization starting points.
-
Digoxin, HIF-1α, and Thyroid Eye Disease Fibrosis
2026-10-01
A 2026 Biochemical and Biophysical Research Communications study identifies HIF-1α as a mechanistic link between hypoxia, inflammation, fibrosis, STAT3 activation, and GSDME-mediated pyroptosis in thyroid eye disease. In primary orbital fibroblasts, low-nanomolar Digoxin suppressed these responses, providing a pharmacological basis for investigating HIF-1α inhibition in TED while leaving important questions about in vivo efficacy and clinical translation unresolved.
-
Prochlorperazine Workflows for Melanoma Research
2026-09-30
Prochlorperazine is a dopamine D2 receptor antagonist that can be deployed beyond antiemetic therapy in integrated melanoma viability, migration, and biomarker workflows. This guide translates reference-study findings into practical assay design, concentration selection, troubleshooting, and cautious antiviral follow-up experiments.
-
Paclitaxel (Taxol) Workflows for Microtubule Research
2026-09-30
Build reproducible Paclitaxel workflows for mitotic arrest, cytoskeletal imaging, endothelial assays, and cancer models. This guide also uses the latest α-tubulin lactylation findings to distinguish microtubule stabilization from metabolism-driven changes in microtubule dynamics.
-
4-Ethylphenyl Sulfate: Renal and Gut-Brain Research
2026-09-29
4-Ethylphenyl sulfate is a microbiota-derived protein-bound uremic toxin and a p-cresol-related research compound. Evidence supports its study in renal dysfunction biomarker workflows and gut microbiota-brain interaction research, while product specifications support controlled in vitro and animal-model use.
-
Nigericin: From Ion Gradients to Assay Design
2026-09-29
Nigericin is a potassium/hydrogen ion carrier that connects intracellular pH modulation with mitochondrial and cell-death biology. This article translates ion-gradient perturbation and NADH–antibiotic metabolism findings into better assay design, controls, and interpretation.
-
Nigericin Workflows for pH and Ion Transport Assays
2026-09-28
Nigericin BA1112 provides a practical way to connect potassium/hydrogen exchange with intracellular pH modulation, mitochondrial membrane ion transport, and cell-death phenotyping. This workflow-focused guide shows how to prepare, dose, monitor, and troubleshoot Nigericin assays while using the NADH–antibiotic literature as a careful framework for metabolic assay design.
-
Prochlorperazine: D2 Antagonism and Research Uses
2026-09-28
Prochlorperazine is a dopamine D2 receptor antagonist used as an antiemetic and investigated in melanoma and antiviral research. Its reported cell-based results and product handling parameters can guide study planning, but preclinical findings do not establish clinical anticancer or antiviral efficacy.
-
(S)-(+)-Ibuprofen: From Dose to Exposure
2026-09-27
Learn how (S)-(+)-Ibuprofen can support COX inhibitor research while its solubility, assay matrix, and environmental fate shape the exposure a study actually measures. This practical perspective connects product specifications with evidence on ibuprofen’s ecological impacts.
-
Diclofenac in Human Intestinal Organoid Research
2026-09-26
Use Diclofenac to probe cyclooxygenase-dependent responses in human iPSC-derived intestinal models, while keeping inflammation readouts distinct from pharmacokinetic claims. This practical guide connects organoid preparation, vehicle-matched dosing, and troubleshooting to the model capabilities—and limitations—reported in a recent study.